Format

Send to

Choose Destination
Curr Hypertens Rep. 2010 Aug;12(4):267-75. doi: 10.1007/s11906-010-0118-2.

Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets.

Author information

1
Department of Angiology, Institut de Recherches Servier, Suresnes, France.

Abstract

Endothelial cells regulate vascular tone by releasing various contracting and relaxing factors including nitric oxide (NO), arachidonic acid metabolites (derived from cyclooxygenases, lipoxygenases, and cytochrome P450 monooxygenases), reactive oxygen species, and vasoactive peptides. Additionally, another pathway associated with the hyperpolarization of the underlying smooth muscle cells plays a predominant role in resistance arteries. Endothelial dysfunction is a multifaceted disorder, which has been associated with hypertension of diverse etiologies, involving not only alterations of the L-arginine NO-synthase-soluble guanylyl cyclase pathway but also reduced endothelium-dependent hyperpolarizations and enhanced production of contracting factors, particularly vasoconstrictor prostanoids. This brief review highlights these different endothelial pathways as potential drug targets for novel treatments in hypertension and the associated endothelial dysfunction and end-organ damage.

PMID:
20532699
PMCID:
PMC2910890
DOI:
10.1007/s11906-010-0118-2
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center